MedTrace Logo

Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

NCT02725242 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2017-04-18

No results posted yet for this study

Summary

This study will evaluate the efficacy of Once-daily Budesonide/formoterol Turbuhaler 160/4.5 µg/d in the period of step down in well controlled asthmatic patient.

Conditions

Interventions

DRUG

Budesonide/formoterol (160/4.5 μg/d)

After the patients who have all criteria, they will be randomization to take Budesonide/formoterol (160/4.5 μg/d)

DRUG

Budesonide (400μg/d)

After the patients who have all criteria, they will be randomization to take Budesonide (200 ug) twice daily

Sponsors & Collaborators

  • Hat Yai Medical Education Center

    lead OTHER

Principal Investigators

  • Narongwit Nakwan, M.D. · HatYai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725242 on ClinicalTrials.gov